New embolic protection devices: A review

Journal of Cardiovascular Surgery

Volumn 52, Issue 6, 2011, Pages 821-827

  Macdonald, S ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Carotid artery diseases; Embolic protection devices; Stents

Indexed keywords

BLOOD FLOW; CAROTID ARTERY STENTING; EMBOLIC PROTECTION DEVICE; HEART CATHETERIZATION; HEART DEATH; HEART INFARCTION; HUMAN; OPERATION DURATION; REVIEW; STROKE; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

ANGIOPLASTY; CAROTID ARTERY DISEASES; EMBOLIC PROTECTION DEVICES; EVIDENCE-BASED MEDICINE; HUMANS; INTRACRANIAL EMBOLISM; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTORS; STENTS; TREATMENT OUTCOME;

EID: 84055222495     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Theron J. Cerebral protection during carotid angioplasty. J Endovasc Surg 1996;3:484-6.
2. Theron J, Venturi C, Reul J, Milosevic Z, Guimaraens L, Beujeux R et al. Immediate and 30-day Clinical Outcomes of Patients Treated with the TwinOne Cerebral Protection System: Multicenter Experience in 217 Cases. CVIR 2009;32:1139-45.
3. Clair DG, Hopkins LN, Mehta M, Kasirajan K, Schermerhorn M, Sconholz C et al. for the EMPiRE Clinical Study Investigators. Neuroprotection During Carotid Artery Stenting Using the GORE Flow Reversal System: 30-Day Outcomes in the EMPiRE Clinical Study. Catheterization and Cardiovascular Interventions 2011;77:420-9.
4. Ansel GM, Hopkins NL, Jaff MR, Rubino P, Bacharach JM, Schienert D et al. and the Investiagtors for the ARMOUR Pivotal Trial. Safety and Effectiveness of the Invatec MOMA® Proximal Cerebral Protection Device During Carotid Artery Stenting: Results From the ARMOUR Pivotal Trial. Catheter Cardiovasc Interv 2010;76:1-8.
5. Myla S, Bacharach M, Ansel GM, Dippel EJ, McCormick DJ, Popma JJ. Carotid Artery Stenting In High Surgical Risk Patients Using The FiberNet® Embolic Protection System: The EPIC Trial Results. Catheterization and Cardiovascular Interventions 2010;75:817-22.
6. Bosiers M, de Donato G, Deloose K, Verbist J, Peeters P, Castriota F et al. Does free cell area influence the outcome in carotid artery stenting EJVES 2007;33:135-41.
7. Jansen O, Fiehler J, Hartmann M, Brückmann H. Protection or nonprotection in carotid stent angioplasty: the influence of interventional techniques on outcome data from the SPACE Trial. Stroke 2009;40:841-6.
8. Biller J, Feinberg WM, Castaldo JE, Whittlemore AD, Haraugh RE, Dempsey RJ et al. Guidelines for carotid endarterectomy: as statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1998;29:1475-6.
9. Pinter L, Ribo M, Loh C, Lane b, Roberts T, Chou TM et al. Safety and feasibility of a novel transcervical access neuroprotection system for carotid artery stenting in the PROOF study. JVS 2011, June 12 [Epub ahead of print].
10. Chang DW, Schubart PJ, Veith FJ, Zarins CK. A new approach to carotid angioplasty and stenting with transcervical occlusion and protective shunting: why it may be a better carotid artery intervention. J Vasc Surg 2004;39:994-1002. (Pubitemid 38581629)
11. Criado E, Doblas M, Fontcuberta J, Orgaz A, Flores A. Transcervical carotid artery angioplasty and stenting with carotid flow reversal: surgical technique. Ann Vasc Surg 2004;18:257-61. (Pubitemid 38509665)
12. Bonati LH, Jongen LM, Haller S, Flach HZ, Dobson J, Nederkoorn PJ et al. ICSS-MRI study group. New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the International Carotid Stenting Study (ICSS). Lancet Neurol 2010;9:353-62.
13. Safian RD, Jaff MR, Bresnahan JF, Foster M, Bacharach JM, Ya-dav J et al. SpideRX Trial Investigators. Protected carotid stenting in high-risk patients: results of the SpideRX arm of the carotid revascularization with ev3 arterial technology evolution trial. J Interv Cardiol 2010;23:491-8.
14. Sprouse LR 2nd, Peters P, Bosiers M. The capture of visible debris by distal cerebral protection filters during carotid artery stenting: Is it predictable? JVS 2005;41:950-5. (Pubitemid 40813021)
15. Whitlow PL, Lylyk P, Londero H, Mendiz OA, Mathias K, Jaeger H et al. Carotid artery stenting protected with a emboli containment system. Stroke 2002;33:1308-14. (Pubitemid 34517052)
16. Henry M, Polydorou A, Henry I, Polydorou A, Hugel M. Carotid angioplasty under cerebral protection with the PercuSurge Guard-Wire System Catheter Cardiovasc Interv 2004;61:293-305. (Pubitemid 38298260)
17. Macdonald S, Gaines PA. Current concepts of mechanical cerebral protection during precutaneous carotid intervention. Vasc Med 2003;8:25-32. (Pubitemid 36789740)
18. Settaci C, Chisci E, Setacci F, Iacopani F, de Donato G, Rossi A. Siena Carotid Artery Stenting Score. A Risk Modelling Study For Individual Patients. Stroke 2010;41:1259-65.
19. Zahn R, Ischinger T, Hochadel M, Mark B, Zeymer U, Schmalz W et al. for the Arbeitsgemeinschaft Leitende Rardiologische Rrankenhausarzte (ALKR). Carotid Artery Stenting: Do Procedural Complications Relate to the Side Intervened Upon?: Results From the Carotid Artery Stent (CAS) - Registry of the Arbeitsgemeinschaft Leitende Rardiologische Rrankenhausarzte (ALRK). System Catheter Cardiovasc Interv 2009;74:1-8
20. Gray WA, Yadav JS, Verta P, Scicli A, Fairman R, Wholey M et al. CAPTURE Trial Collaborators. The CAPTURE registry: predictors of outcomes in carotid artery stenting with embolic protection for high surgical risk patients in the early post-approval setting. Catheter Cardiovasc Interv 2007;70:1025-33-
21. Mas JL, Chatellier G, Beyssen B, Branchereau A, Moulin T, Becquemin JP et al. EVA-3S Investigators. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med. 2006 Oct 19;355:1660-71. (Pubitemid 44583956)
22. Verzini F, Cao P, De Rango P, Parlani G, Maselli A, Romano L, Norgiolini L, Giordano G. Appropriateness of learning curve for carotid artery stenting: an analysis of periprocedural complications. J Vasc Surg 2006;44:1205-11; discussion 1211-2.
23. Macdonald S, Evans DH, Griffiths PD, McRevitt FM, Venables GS, Cleveland TJ et al. Filter-protected versus unprotected carotid artery stenting: a randomised trial. Cerebrovasc Dis 201029:282-9.
24. Barbara JE, Dillavou E, Horowitz MB, Jovin TG, Ranal E, David S et al. A randomized trial of carotd artery stenting with and without cerebral protection. JVS 2008;47:760-5.
25. Montorsi P, Caputi L, Galli S, Ravagnani R, Boiti C, Ballerini G et al. Randomised Trial of Proximal versus Distal Cerebral Protection on Microembolization During Carotid Artery Stenting in Patients With High Risk Lipid Plaque. Presented at the European Society Of Cardiology Congress, 2010.
26. Schmidt A, Diederich RW, Scheinert S, Bräunlich S, Olenburger T, Biamino G et al. Effect of two different neuroprotection systems on microembolization during carotid artery stenting. J Am Coll Cardiol 2004;44:1966-9. (Pubitemid 39473279)
27. Gupta N, Corriere MA, Dodson TF, Chaikof EL, Beaulieu RJ, Reeves JG et al. The incidence of microemboli to the brain is less with endarterectomy than with percutaneous revascularization with distal filters of flow reversal. JVS 2011;53:316-22
28. Palombo G, Faraglia V, Stella N, Giugni E, Bozzao A, Taurino M. Late evaluation of silent cerebral ischemia detected by diffusion-weighted MR imaging after filter-protected carotid artery stenting. AJNR Am J Neuroradiol 2008;29:1340-3.
29. Altinbas A, van Zandvoort MJ, van den berg E, Jongen LM, Algra A, Moll FL et al. Cognition after carotid endarterectomy or stenting: A randomized comparison. Neurology 2011 [Epub ahead of print].